Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|November 8, 2019
Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled TrialsJoseph E Tota, Frank Struyf, Joshua N Sampson, et al.
Medical Image Learning with Limited and Noisy Data : First International Workshop, Milland 2022, Held in Conjunction with MICCAI 2022, Singapore, September 22, 2022, Proceedings. Milland (Workshop) (1St : 2022 : Singapore)|October 31, 2022
Image Quality Classification for Automated Visual Evaluation of Cervical PrecancerZhiyun Xue, Sandeep Angara, Peng Guo, et al.
International Journal of Cancer|September 29, 2023
A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional studyFederica Inturrisi, Silvia de Sanjosé, Kanan T Desai, et al.
The Lancet. Oncology|August 26, 2011
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine TrialAimée R Kreimer, Paula González, Hormuzd A Katki, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assayHilary A Robbins, Tim Waterboer, Carolina Porras, et al.
Scientific Reports|February 12, 2020
Anthropometry, body shape in early-life and risk of premenopausal breast cancer among Latin American women: results from the PRECAMA studyMathilde His, Carine Biessy, Gabriela Torres-Mejía, et al.
Scientific Reports|October 18, 2024
Temporal trends, spatial and spatiotemporal clusters of cervical cancer mortality in Brazil from 2000 to 2021Matheus Santos Melo, Shirley Verônica Melo Almeida Lima, Allan Danta Dos Santos, et al.
The Journal of Infectious Diseases|August 2, 2012
Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa RicaFelipe A Castro, Wim Quint, Paula Gonzalez, et al.
Elife|January 15, 2024
Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategySilvia de Sanjosé, Rebecca B Perkins, Nicole Campos, et al.
The Journal of Infectious Diseases|September 5, 2020
Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA StudyJoseph E Tota, Frank Struyf, Allan Hildesheim, et al.
Pageof 10